Quest Diagnostics Acquires Haystack Oncology for $300M in Cash
Haystack Oncology was founded to dramatically improve patient outcomes with transformative precision oncology.What You Should Know:Quest Diagnostics has reached an agreement to acquire Haystack Oncology an early-stage oncology company focused on minimal residual disease (MRD) testing to aid…
Continue Reading
